Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bleicher, Jeremy
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation	Completed	4	339	US	Dronedarone, Multaq	American Heart Association, Duke Clinical Research Institute, Sanofi	Atrial Fibrillation	01/24	06/24
COVER-CoAd, NCT05543642: The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients	Active, not recruiting	4	129	US	Hepatitis A vaccine, Havrix, Diphtheria, pertussis, and tetanus booster vaccine, Boostrix	Oregon Health and Science University	Rheumatic Diseases	01/25	12/25
NCT05118074: Nova Max Creatinine and eGFR Meter System	Suspended	N/A	360	US	Creatinine, eGFR	Nova Biomedical, South Florida Research Organization, Charisma Medical and Research Center, Excellence Medical Research	Chronic Kidney Diseases, Acute Kidney Injury	10/24	10/24
NCT04595968: Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus	Completed	N/A	267	Europe, US	Vestal DM Active device, Lifestyle modification, Vestal DM Sham device	Neurovalens Ltd., University College Dublin, CS Lifescience, Clinical Trial Mentors	Type 2 Diabetes	08/24	08/24